Mizuho Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$981K Sell
15,561
-5,806
-27% -$376K 0.21% 123
2016
Q2
$1.32M Buy
21,367
+10,406
+95% +$634K 0.24% 118
2016
Q1
$642K Sell
10,961
-10,269
-48% -$572K 0.17% 147
2015
Q4
$1.26M Buy
21,230
+2,448
+13% +$141K 0.26% 112
2015
Q3
$1.02M Buy
18,782
+3,826
+26% +$249K 0.23% 124
2015
Q2
$1M Buy
14,956
+3,995
+36% +$261K 0.23% 125
2015
Q1
$642K Buy
10,961
+3,909
+55% +$236K 0.17% 147
2014
Q4
$461K Buy
7,052
+1,872
+36% +$118K 0.14% 147
2014
Q3
$299K Buy
5,180
+1,212
+31% +$67.3K 0.06% 167
2014
Q2
$224K Buy
3,968
+799
+25% +$41.9K 0.05% 186
2014
Q1
$163K Hold
3,169
0.03% 189
2013
Q4
$167K Hold
3,169
0.03% 188
2013
Q3
$142K Hold
3,169
0.02% 203
2013
Q2
$131K Buy
+3,169
New +$139K 0.02% 206

Other funds holding ABBV

Mizuho Asset Management's ABBV Position: Q3 2016 in Review

Mizuho Asset Management reduced its AbbVie (ABBV) stake by 27% in Q3 2016, selling an estimated $376K and leaving 15,561 shares worth $981K. The position accounts for 0.21% of the portfolio, ranked #123.

Mizuho Asset Management first reported a position in ABBV in Q2 2013 and has held it in 14 quarters since. The position peaked at $1.32M in Q2 2016. 1,653 funds tracked by Wall St. Rank hold ABBV as of Q3 2016.

  • Mizuho Asset Management held 15,561 shares of AbbVie worth $981K as of Q3 2016.
  • Mizuho Asset Management sold 5,806 AbbVie shares in Q3 2016, an estimated $376K.
  • AbbVie made up 0.21% of Mizuho Asset Management's portfolio in Q3 2016, its #123 holding.
  • Mizuho Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 14 quarters since.
  • Mizuho Asset Management's AbbVie position peaked at $1.32M in Q2 2016.
  • 1,653 funds tracked by Wall St. Rank held AbbVie as of Q3 2016.

Based on Mizuho Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.